Changes

|firstinit=S. |last1author-link=Stephen Moses |last2=Plummer |first1init2=F.A.FA |last2last3=Bradley |first2init3=J.E.JE |last3last4=Ndinya-Achola |first3init4=J.O.JO |last4last5=Nagelkerke |first4init5=N.J.NJ |last5last6=Ronald |first5init6=A.R.AR

|firstinit=J.N.JN

|first2init2=R.C.RC

|first3init3=J.

}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an [[HIV ]] prevention method.<ref>{{REFweb

According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/[[HIV ]] transmission.<ref name='moses-bio'>{{REFweb |last=Dr. Moses

|title=Dr. Stephen Moses

|publisher={{UNI|University of Manitoba|UManitoba}}

|publisher=[[Doctors Opposing Circumcision(D.O.C.)]]

}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV ]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>{{RCT Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. ''Lancet'' 2007;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]}}</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.

Moses' research on circumcision protection from [[HIV ]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV ]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{REFjournal |last=Boyle |first=Gregory J. |author-link= |last2=Hill |first2=George |author2-link=George Hill |title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns |journal=J Law Med |date=BoyleGJ HillG 2011-12 |volume=19 |issue=2 |pages=316-334 |url=http://www.salem-news.com/fms/pdf/2011-12_JLM-Boyle-Hill.pdf |quote= |pubmedID=22320006 |pubmedCID= |DOI= |accessdate=2020-03-23}}</ref> [[Michel Garenne|Garenne ]] & Matthews (2019) report that circumcised men have as much [[HIV ]] infection as intact men.<ref>{{REFjournal

|firstinit=M |author-link=Michel Garenne

|first2init2=A

* A randomized, controlled trial of male circumcision to reduce [[HIV ]] incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small>* Scaling up [[HIV ]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>

* Mapping key populations for [[HIV ]] prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small>

== Recent publications =={{PUB}}* Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{REFjournal

|firstinit=J.S.JS

|first2init2=D.M.DM

|first3init3=MMG |last4=Bailey |first4=Robert C.G |init4=RC |author4-link=Robert C.Bailey |last5=Agot |init5=K |last6=Ndinya-Achola |init6=JO |last7=Moses |init7=S |author7-link=Stephen Moses

}}</ref><br><small>Smith JS, Hudgens MG, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7.</small>* Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal

|firstinit=S. |author-link=Stephen Moses

|title=Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission |journal=CIHR/CMAJ

}}</ref><br><small>Moses S. CIHR/CMAJ 2009; 181: E134-5.</small>* Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal

|firstinit=S.D.SD

|first2init2=R.RH |author2-link=Ronald H.Gray

|first3init3=B |author3-link=Bertran Auvert |last4=Moses |init4=S |author4-link=Stephen Moses |last5=Kigozi |init5=G |author5-link=Godfrey Kigozi |last6=Taljaard |init6=D |last7=Puren |init7=A |last8=Agot |init8=K |last9=Serwadda |init9=D |other=Parker CB, [[Maria Wawer|Wawer MJ]], [[Robert C.Bailey|Bailey RC]]

</ref><br><small>Mehta SD, '''[[Ronald Gray|Gray RH]]''', '''[[Bertran Auvert|Auvert B]]''', Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, '''[[Maria Wawer|Wawer MJ]]''', '''[[Robert C. Bailey|Bailey RC]]'''. AIDS 2009; 23: 1557-64.</small>* Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal |last=RCT Bailey |first=R.C. |last2=Moses |first2=S. |last3=Parker |first3=C.B. |etal=yes |date=et al 2007-02 |title=Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial |journal=Lancet |volume=369 |issue=9562 |pages=643–56 |url= |pubmedID=17321310 |DOI=10.1016/S0140-6736(07)60312-2 |accessdate=}}</ref><br><small>'''[[Robert C. Bailey|Bailey RC]]''', Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56.</small>* Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal

|firstinit=N.J.NJD

|first2init2=S. |author2-link=Stephen Moses

|first3init3=S.J.SJ

|first4init4=R.RC |author4-link=Robert C.Bailey

}}</ref><br><small>Nagelkerke NJD, Moses S, de Vlas S, '''[[Robert C. Bailey|Bailey RC]]'''. BMC Infect Dis 2007; 7: 16.</small>* Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal

|firstinit=J.N.JN

|first2init2=R.RC |author2-link=Robert C.Bailey |last3=OpeyaAgot |init3=K |first3last4=Parker |init4=J.C. |last5=Ndinya-Achola |init5=JO |last6=Moses |init6=S |author6-link=Stephen Moses

|journal=Urol. Int.

[[Category:PeoplePerson]][[Category:Male]]